FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, namely neurology. In the acute period after the verification of the etiology of the disease, the content of alpha-1-antitrypsin in the liquor is determined and a 2-hour EEG monitoring is performed. When establishing the etiology of the disease caused by viruses of herpes simplex type 1 and type 2 or human herpesvirus type 6, alpha-1-antitrypsin level in CSF above 0.045 g/l and registration of EEG focal epileptiform activity predict the development of symptomatic epilepsy.
EFFECT: method allows to increase the reliability of the forecast, which is achieved through the identification and recording of indicators of the above signs of the disease.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF DEVELOPING SYMPTOMATIC EPILEPSY ACCOMPANYING NEUROINFECTIONS IN CHILDREN | 2013 |
|
RU2537886C1 |
| METHOD FOR PREDICTING THE UNFAVORABLE COURSE OF EPILEPSY IN CHILDREN IN THE FIRST YEAR OF LIFE | 2022 |
|
RU2787512C1 |
| METHOD FOR DIAGNOSING NEUROIMMUNE DISORDERS IN YOUNG CHILDREN WITH EPILEPSY | 2021 |
|
RU2767271C1 |
| METHOD FOR PREDICTION OF INDIVIDUAL RISK OF DEVELOPING POST-TRAUMATIC EPILEPSY | 2019 |
|
RU2725132C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF INFECTIOUS ENCEPHALITIS IN CHILDREN | 2023 |
|
RU2824592C1 |
| METHOD FOR NEUROIMAGING PREDICTION OF THE OUTCOME OF VIRAL ENCEPHALITIS IN CHILDREN IN THE ACUTE PERIOD OF THE DISEASE | 2022 |
|
RU2790195C1 |
| METHOD OF LEUKOENCEPHALITIS TREATMENT IN CHILDREN | 2007 |
|
RU2348411C2 |
| METHOD FOR PREDICTING DEVELOPMENT COURSE AND OUTCOME OF HERPETIC ENCEPHALITIS IN EARLY AGE CHILDREN | 2000 |
|
RU2173955C1 |
| METHOD FOR TREATMENT OF VIRAL ENCEPHALITIS IN CHILDREN | 2022 |
|
RU2786753C1 |
| METHOD FOR SEROUS MENINGITIS OUTCOMES PREDICTION FOR CHILDREN | 2015 |
|
RU2612539C2 |
